Back to Search
Start Over
O13-4 Tepotinib safety in MET exon 14 (METex14) skipping NSCLC: Updated results from the VISION trial.
- Source :
-
Annals of Oncology . 2021 Supplement 3, Vol. 32, pS291-S291. 1p. - Publication Year :
- 2021
- Subjects :
- *NON-small-cell lung carcinoma
*ANTINEOPLASTIC agents
*MEDICATION safety
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 32
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152687071
- Full Text :
- https://doi.org/10.1016/j.annonc.2021.05.541